Axillary treatment for operable primary breast cancer: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Axillary Treatment for Operable Primary Breast Cancer: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435822/all/Blunt_versus_sharp_suture_needles_for_preventing_percutaneous_exposure_incidents_in_surgical_staff:_Cochrane_systematic_review. Accessed 23 April 2024.
Axillary treatment for operable primary breast cancer: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435822/all/Blunt_versus_sharp_suture_needles_for_preventing_percutaneous_exposure_incidents_in_surgical_staff:_Cochrane_systematic_review. Accessed April 23, 2024.
Axillary treatment for operable primary breast cancer: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435822/all/Blunt_versus_sharp_suture_needles_for_preventing_percutaneous_exposure_incidents_in_surgical_staff:_Cochrane_systematic_review
Axillary Treatment for Operable Primary Breast Cancer: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435822/all/Blunt_versus_sharp_suture_needles_for_preventing_percutaneous_exposure_incidents_in_surgical_staff:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Axillary treatment for operable primary breast cancer: Cochrane systematic review
ID - 435822
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435822/all/Blunt_versus_sharp_suture_needles_for_preventing_percutaneous_exposure_incidents_in_surgical_staff:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -